Ukraine has a long tradition of performing high-quality clinical trials in a timely manner. The concentration of patients in just a few hospitals, access to innovative therapies, and the quality training received by investigators and other staff members, have made Ukraine an ideal country for clinical trials in the last 20 years. However, the war has created numerous challenges in myriad areas of the country, and Medical Affairs is no exception. Check out this article from the Lancet, which examines Ukrainian clinical trials before the war and what measures trialists are taking to ensure the country’s positive reputation for good clinical trials persists in spite of the war.
“Some researchers believe that investment by foreign companies would be one way of not just rebuilding the medical research sector, if and when the conflict does end, but also showing faith in the wider health-care sector.”1
“What I hope is that once we win this war and it ends, one way for support to be shown for Ukraine is to raise the number of trials, because the Ukrainian health-care system will be in a bad way for a long time because of this war and having more trials would be one way of helping it recover.”1
Read the complete article here.
Disclaimers
- The material in these reviews is from various public open access sources, meant for educational and informational purposes only
- Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
- No official support by any organization(s) has been provided or should be inferred
References
- Holt, E. (2022). Clinical triallists in Ukraine determined to continue. The Lancet, 399(10336), 1680–1681. https://doi.org/10.1016/s0140-6736(22)00773-5
